Publication:
2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgery

dc.contributor.authorSerena Cappuccio
dc.contributor.authorRiccardo Oliva
dc.contributor.authorClaudia Marchetti
dc.contributor.authorBarbara Costantini
dc.contributor.authorGianfranco Zannoni
dc.contributor.authorGiovanni Scambia
dc.contributor.authorAnna Fagotti
dc.date.accessioned2026-10-25T13:37:49Z
dc.date.issued2022-10-01
dc.identifier.doi10.1136/ijgc-2022-esgo.603
dc.identifier.issn1048-891X
dc.identifier.startpageA284
dc.identifier.urihttps://doi.org/10.1136/ijgc-2022-esgo.603
dc.identifier.urihttps://hdl.handle.net/20.500.12645/42715
dc.identifier.volume32
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofInternational Journal of Gynecological Cancer
dc.rightsopenAccess
dc.sourceOpenAire
dc.title2022-RA-950-ESGO Low grade and high grade serous ovarian cancer: comparison of surgical outcome after secondary cytoreductive surgeryen
dc.typeArticle
dspace.entity.typePublication

Files